Steinbrunn-le-Bas, France

Eric Chevalier

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Eric Chevalier: Innovator in Pharmaceutical Aerosols

Introduction

Eric Chevalier, an accomplished inventor based in Steinbrunn-le-Bas, France, has carved a niche in the field of pharmaceutical innovations. With a total of four patents to his name, Chevalier’s contributions focus primarily on the development of therapeutic aerosols aimed at treating various pulmonary diseases.

Latest Patents

One of Eric Chevalier's latest patents is titled "Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof." This innovative invention encompasses pharmaceutical aerosols incorporating a β-hairpin peptidomimetic featuring the formula cyclo(-OctG-Glu-Thr-Ala-Ser-Ile-Pro-Pro-Gln-Lys-Tyr-Pro-Pro-). The compound exhibits significant inhibitory activity against human neutrophil elastase and is designed for managing conditions such as alpha-1 antitrypsin deficiency (AATD), cystic fibrosis (CF), and chronic obstructive pulmonary disease (COPD). It also addresses other infections and lung-related diseases linked to human neutrophil elastase activity. The invention further extends to pharmaceutical compositions and kits tailored for the effective preparation and administration of these aerosols.

Career Highlights

Eric Chevalier is a key figure at Polyphor AG, where he has contributed to pioneering advancements in the pharmaceutical sector. His work is instrumental in enhancing therapeutic methods for respiratory illnesses, showcasing his commitment to innovation and patient care.

Collaborations

During his career, Chevalier has collaborated with notable professionals such as Johann Zimmermann and Françoise Jung. These partnerships underline the collaborative spirit prevalent in the field of pharmaceutical research, contributing to the successful realization of innovative treatments.

Conclusion

In summary, Eric Chevalier is a distinguished inventor whose work in aerosol therapeutics is making significant strides in the treatment of pulmonary diseases. His latest patents reflect a deep understanding of pharmaceutical science and a dedication to improving therapeutic options for patients, solidifying his position as a leader in innovation within the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…